Inventor · disambiguated record
Craig Andrew Miller
Also filed as: MILLER CRAIG · MILLER CRAIG ANDREW
12 granted patents·3 pending applications·62 citations·filing 2005–2024
87Inventor score
Files withBOEHRINGER INGELHEIM INT6BOEHRINGER INGELHEIM PHARMA4ABEYWARDANE ASITHA1BARBOSA JR ANTONIO JOSE DEL MORAL1COGAN DEREK1
Top patents by PatentIndex Score
15 records- 0193US7514458B2Anti-cytokine heterocyclic compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2007·Granted Apr 7, 2009·25 cites·10 claims
- 0288US7214802B2Anti-cytokine heterocyclic compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted May 8, 2007·12 cites·18 claims
- 0387US9868749B2Fused imidazole and pyrazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 16, 2018·16 cites·7 claims
- 0484US2025042901A1Heteroaryl carboxamide compounds as inhibitors of ripk2BOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0580US7790712B2Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted Sep 7, 2010·5 cites·5 claims
- 0678US11130754B2Substituted benzamides as RIPK2 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Sep 28, 2021·1 cites·14 claims
- 0775US12139484B2Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel diseaseBOEHRINGER INGELHEIM INT·Filed 2021·Granted Nov 12, 2024·0 cites·23 claims
- 0874US10138241B2Substituted benzamides as RIPK2 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Nov 27, 2018·1 cites·52 claims
- 0969US8586748B22-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10ABEYWARDANE ASITHA·Filed 2009·Granted Nov 19, 2013·1 cites·5 claims
- 1063US8552205B2Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amidesBARBOSA JR ANTONIO JOSE DEL MORAL·Filed 2008·Granted Oct 8, 2013·1 cites·49 claims
- 1151US2006276496A1Anti-Cytokine Heterocyclic CompoundsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 1249US8859814B2Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using themCOGAN DEREK·Filed 2009·Granted Oct 14, 2014·0 cites·4 claims
- 1342US2010190773A1Anti-Cytokine Heterocyclic CompoundsBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 1439US10138222B2Substituted benzamides as RIPK2 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Nov 27, 2018·0 cites·33 claims
- 1527US8575360B2Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amidesLEMIEUX RENE MARC·Filed 2010·Granted Nov 5, 2013·0 cites·34 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →